Page last updated: 2024-08-26

arsenic and Cell Transformation, Neoplastic

arsenic has been researched along with Cell Transformation, Neoplastic in 174 studies

Research

Studies (174)

TimeframeStudies, this research(%)All Research%
pre-199011 (6.32)18.7374
1990's9 (5.17)18.2507
2000's47 (27.01)29.6817
2010's91 (52.30)24.3611
2020's16 (9.20)2.80

Authors

AuthorsStudies
Chiu, JF; Huang, N; Li, G; Lin, W; Pei, X; Tao, T1
Chan, TC; Chang, WR; Chiou, SH; Fang, KM; Lin, TC; Liu, JJ; Ma, SZ; Tzeng, SF; Tzou, BC; Yang, CS1
Ayoubi, HR; Bazarbachi, AA; Bitar, NM; De Thé, HB; El Eit, RM; Iskandarani, AN; Jabbour, MN; Mahfouz, RA; Mahon, FX; Nasr, RR; Saliba, JL; Zaatari, GS1
Kojima, C; Tokar, EJ; Waalkes, MP1
Dos Santos, GA; Kats, L; Pandolfi, PP1
de Thé, H; Rice, KL1
Hasan, SK; Lo-Coco, F1
Ablain, J; de Reynies, A; de Thé, H; Halftermeyer, J; Le Bras, M; Metzger, D; Peres, L; Vitaliano-Prunier, A1
Huang, HS; Liu, ZM; Tseng, HY; Wu, WJ; Yeh, BW1
Gao, B; Lu, M; Meng, X; Miao, Z; Qiao, X; Wu, L; Xue, D; Zhang, W1
An, Y; Hoshino, M; Kato, K; Mizoi, M; Nakanao, M; Okada, S; Yamanaka, K1
Mandal, P1
Gou, BD; Wang, K; Wang, LW; Wang, N; Zhang, TL1
Brossart, P; Czarnocka, B; Fröhlich, E; Wahl, R1
Eblin, KE; Futscher, BW; Gandolfi, AJ; Jensen, TJ; Wnek, SM; Wozniak, RJ1
Hayashi, K; Kuroda, S; Muramatsu, D; Sakai, A; Sasaki, K; Tanaka, N1
Cao, L; Dunlevy, JR; Garrett, SH; Sens, DA; Sens, MA; Somji, S; Zheng, Y; Zhou, XD1
de Thé, H; Nasr, R1
Kurokawa, M; Nagai, S; Takahashi, T1
Qu, W; Tokar, EJ; Waalkes, MP1
Beezhold, K; Castranova, V; Chen, F; Kan, H; Liu, J; Meighan, T; Shi, X1
Chen, C; Edin, ML; Gong, W; Li, Y; Liu, L; Wang, DW; Zeldin, DC1
Arnold, SM; Budhraja, A; Cheng, S; Li, L; Li, W; Shelton, BJ; Shi, X; Son, YO; Sun, L; Tucker, T; Wang, X; Yao, H; Zhang, Z1
Byers, LA; Carter, B; Chiang, CM; Girard, L; Heymach, JV; Konstantinidou, G; Rabellino, A; Rimessi, A; Scaglioni, PP; Teruya-Feldstein, J; Wu, SY1
Chen, SJ; Chen, Z; Li, JM; Mi, JQ; Shen, ZX1
Barnett, JB; Davis, ME; Holaskova, I; Jiang, BH; Lu, Y; Rojanasakul, Y; Schafer, R; Stueckle, TA; Wang, L1
Bode, AM; Dong, Z; Kim, DJ; Kim, HG; Lee, KY; Li, S; Li, X1
Shih, HM; Yang, WC1
Hock, JM; Li, X; Liu, Y; Van Beneden, RJ1
Garrett, SH; Gurel, V; Park, S; Sens, DA; Sens, MA; Somji, S1
Barrett, JC; Ochi, T; Suzuki, T; Tsutsui, T1
Ando, M; Jinno, H; Sakimoto, K; Tanaka-Kagawa, T; Tokunaga, H; Tsuchiya, T; Umeda, M1
Beal, N; Diehl, LF; Huff, CA; Jones, RJ; Matsui, W; Smith, BD; Vala, M1
Gogvadze, V; McConkey, DJ; Mirnikjoo, B; Nutt, LK; Orrenius, S; Uthaisang, W1
Chen, GQ; Huang, Y; Jiang, Y; Liu, W; Peng, ZG; Song, LP; Zhao, Q1
Horváth, V; Ondrousková, E; Smarda, J; Soucek, K1
Eblin, KE; Futscher, BW; Gandolfi, AJ; Jensen, TJ; Novak, P1
Bredfeldt, TG; Eblin, KE; Gandolfi, AJ1
Dominok, B; Geppert, H1
Chen, G; Shi, G; Tang, W1
Ikeda, Y; Kinjo, K; Kizaki, M; Muto, A; Ueno, H1
Hamadeh, HK; Lee, E; Menzel, DB; Vargas, M1
Zhang, T1
Chen, L; Jiang, S; Liang, Y1
Bode, AM; Dong, Z2
Krause, H1
Fischbach, M; Gallorini, M; Pietra, R; Piette, JL; Pozzi, G; Sabbioni, E1
Baffes, T; Dakin, A; Galt, RM; Haefliger, R; Knock, FE; Oester, YT; Renaud, OV; Rubnitz, M; Sylvester, R; Thomson, B1
Fang, X; Gao, L; Guo, T; Hu, Y; Li, Y; Liu, Y; Pi, J; Ruan, Y; Wang, X; Xu, Y1
Almutairy, B; Bi, Z; Chen, F; Fu, Y; Li, L; Qiu, Y; Seno, A; Thakur, C; Wadgaonkar, P; Zhang, W1
Almutairy, B; Bi, Z; Chen, F; Fu, Y; Qiu, Y; Thakur, C; Wadgaonkar, P; Zhang, W1
An, Y; Deng, H; Jin, T; Kato, K; Li, C; Mo, Y; Wang, X; Xia, H; Yan, R; Yang, Q; Zhang, H; Zhang, J1
Adam, RM; Chandrasekaran, B; Damodaran, C; Navin, AK; Saran, U; Shukla, V; Tyagi, A1
Almutairy, BS; Bi, Z; Chen, F; Fu, Y; Ji, H; Pawar, AS; Qiu, Y; Seno, A; Thakur, C; Wang, Z; Zhang, W1
Berindan-Neagoe, I; Gurzau, E; Manda, G; Schitcu, V; Stavaru, C; Szedlacsek, S; Zimta, AA1
Martínez-Pacheco, M; Rodríguez-Sastre, MA; Rojas, E; Valverde, M1
Chen, S; Pi, J; Sun, R; Wang, F; Wang, H; Wu, X; Xu, H; Xu, Y; Yang, B; Zhao, R1
Bhattacharjee, P; Das, A; Giri, AK1
Almutairy, B; Bi, Z; Chang, Q; Chen, F; Fu, Y; Lu, Y; Rice, MKA; Thukar, C; Wadgaonkar, P; Xu, L; Zhang, Q; Zhang, W1
Harkema, J; Kumagai, K; Lin, HP; Wang, Z; Xie, J; Yang, C; Yang, P1
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z1
Hu, DP; Hu, WY; Li, Y; Prins, GS; Shi, G; Xie, L; Yang, J1
Chen, Y; Fu, L; Han, Y; He, X; Li, X; Liu, L; Wang, Z; Wu, L; Zhang, T1
Clementino, M; Fenske, W; Li, Y; Lin, HP; Wang, C; Wang, Z; Xie, J; Yang, C; Yang, P1
Bach, J; Barguilla, I; Hernández, A; Marcos, R; Peremartí, J1
Pi, J; Tokar, EJ; Xu, Y1
Almutairy, B; Bi, Z; Chen, F; Fu, Y; Qiu, Y; Seno, A; Thakur, C; Wadgaonkar, P; Xu, L; Zhang, Q; Zhang, W1
Ahsan, H; Cui, X; Cui, YH; He, C; He, YY; Kibriya, MG; Shah, P; Shea, CR; Wang, F; Wei, J; Yang, S; Zhong, W1
Chen, G; Chen, J; Cui, J; Dai, L; Frank, JA; Li, H; Peng, S; Wang, S; Xu, W1
Chen, QY; Costa, M1
Bhattacharjee, P; Giri, AK; Paul, S1
Grillari, J; Groza, D; Grusch, M; Heffeter, P; Kryeziu, K; Mildner, M; Nagelreiter, F; Rösinger, S; Schoenhacker-Alte, B; Schosserer, M; Tav, K; Tschachler, E; Weinmuellner, R; Wimmer, L; Zbiral, B1
Chen, Z; Ding, Y; Fang, H; Jiang, Y; Li, F; Li, J; Liu, Y; Wang, S; Wang, X; Xu, M; Yang, J1
Kujur, PK; Mishra, A; Rajput, M; Singh, RP1
Fondufe-Mittendorf, Y; Gripshover, T; Rea, M1
Begum, A; Hoque, MO; Kates, M; Mao, S; Marchionni, L; Ooki, A; VandenBussche, CJ1
Chen, QY; Costa, M; DesMarais, T; Jordan, A; Kluz, T; Li, J; Murphy, A; Sun, H; Wu, F; Zhang, X; Zhu, Y1
Al-Eryani, L; Cardoso, APF; States, JC1
An, Y; Deng, H; Li, C; Ni, Y; Wang, X; Zhu, Z1
Luz, AL; Makia, N; Ngalame, NNO; Tokar, EJ1
Cao, Z; Huang, Z; Li, X; Li, Y; Lin, Z; Ma, X; Wang, H; Wang, L; Zhang, F; Zhong, M1
Lynch, RM; Perry, A; Rusyn, I; Threadgill, DW1
Gao, Y; Qiao, R; Su, X; Wang, L; Wang, S; Yin, H; Zhao, Y1
Bi, Z; Chen, F; Fu, Y; Li, L; Lu, Y; Thakur, C; Wadgaonkar, P; Wang, L; Zhang, Q1
Chang, YW; Singh, KP1
Barajas-Olmos, FM; Centeno, F; Córdova-Alarcón, EJ; Cruz-Colín, JL; Imaz-Rosshandler, I; Martínez-Tovar, A; Morales-Marín, ME; Orozco, L; Ortiz-Sánchez, E; Rangel, C; Villanueva-Toledo, J1
Ablain, J; Anthony, E; de Thé, H; Fonsart, J; Leiva, M; Peres, L1
Guo, F; Guo, S; Huang, S; Kawanishi, S; Ma, N; Murata, M; Ohnishi, S; Xiao, X; Yang, Q1
Arora, M; Kaul, D; Sharma, M; Sharma, S1
Singh, KP; Treas, J; Tyagi, T1
Tokar, EJ; Waalkes, MP; Xu, Y1
Garrett, SH; Sens, DA; Somji, S; Zhang, KK1
Chang, Q; Chen, B; Chen, F; Lu, Y; Thakur, C1
Rodríguez-Sastre, MA; Rojas, E; Valverde, M1
Chen, G; Dai, L; Frank, JA; Li, H; Liu, H; Qi, Y; Wang, C; Zhang, M; Zhang, Z1
Kato, M; Kumasaka, MY; Naito, H; Ohgami, N; Ohnuma, S; Omata, Y; Shekhar, HU; Yajima, I1
Budhraja, A; Kim, D; Pratheeshkumar, P; Shi, X; Son, YO; Zhang, Z1
Ahsan, H; Argos, M; Baras, A; Bivalacqua, TJ; Brait, M; Datta, S; Hahn, NM; Hayashi, M; Hoque, MO; Izumchenko, E; Michailidi, C; Netto, GJ; Oladeru, O; Sen, T; Sidransky, D; VandenBussche, C; Zenner, K1
Brocato, J; Chen, D; Costa, M; Fang, L; Jin, C; Liu, J1
Bode, AM; Dong, Z; Kim, HG; Shi, C1
Ballinas-Casarrubias, L; Currier, JM; Del Razo, LM; Drobná, Z; Fry, RC; García-Vargas, GG; González-Horta, Mdel C; Gutiérrez-Torres, DS; Ishida, MC; Kim, WY; Rager, JE; Ray, PD; Sánchez-Ramírez, B; Smeester, L; Stýblo, M; Tilley, SK; Tulenko, SE; Wright, FA; Yosim, A; Zhou, YH1
An, Y; Chen, M; Fu, L; Gao, F; Ma, Y; Wang, D; Wang, X; Xu, F; Xu, X; Yang, X; Zhao, Y; Zhu, J; Zhu, Z1
Chen, G; Divya, SP; Hitron, JA; Luo, J; Pratheeshkumar, P; Roy, RV; Shi, X; Son, YO; Wang, L; Xu, M; Zhang, Z1
Ge, X; He, J; Jiang, BH; Jiang, C; Li, D; Liu, J; Liu, LZ; Liu, X; Qin, L; Shi, Z; Wang, L; Wang, M; Yang, H; Zhen, L; Zheng, J1
Bruce, SW; Gairola, CG; Han, SG; Pant, K1
Martínez-Baeza, E; Rojas, E; Valverde, M1
Eckstein, M; Eleazer, R; Fondufe-Mittendorf, YN; Jiang, T; Marshall, AG; Rea, M1
Chen, H; Chiu, JF; Lee, LS; Li, G; Tsao, SW1
Nohara, K; Okamura, K; Suzuki, T; Takumi, S1
Divya, SP; Pratheeshkumar, P; Shi, X; Son, YO; Wang, L; Zhang, Z1
He, YY; Hu, WY; Pi, J; Prins, GS; Qiang, L; Shah, P; Trinh, E; Xie, L1
Eckstein, M; Eleazer, R; Fondufe-Mittendorf, YN; Rea, M; Smith, C1
Dibble, CC; Huang, Y; Kim, MM; Lopez-Pajares, V; McHenry, KT; Mizgerd, JP; Yuan, ZM; Zeng, W; Zhang, J1
Galanis, A; Karapetsas, A; Sandaltzopoulos, R1
Kawata, K; Okabe, S; Shimazaki, R1
Licht, JD1
Chang, CH; Chang, LW; Lan, CC; Lee, CH; Liao, WT; You, HL; Yu, CL; Yu, HS1
Chien, CW; Ho, IC; Lee, TC1
Futscher, BW; Gandolfi, AJ; Jensen, TJ; Novak, P; Wnek, SM1
Diwan, BA; Tokar, EJ; Waalkes, MP1
Arita, A; Costa, M1
Chang, Q; Chen, F; Pan, J; Shi, X; Wang, X; Zhang, Z1
Acharya, S; Begum, Z; Chatterjee, S; Chaudhuri, S; Dasgupta, S; Flora, SJ; Kumar, P1
Guo, X; Guo, Y; Miller, R; Wang, Q; Yang, HS; Zhang, Y1
Brabletz, T; Drew, PA; Goodall, GJ; Smith, E; Wang, Z; Yang, C; Zhao, Y1
Lisanti, MP; Martinez-Outschoorn, UE; Pavlides, S; Sotgia, F1
Chen, GS; Hong, CH; Lee, CH; Liao, WT; Wei, YH; Wu, CY; Wu, SB; Yu, HS1
Cohen, SM1
Yu, HS1
Fisher, T; Jiang, Y; Wang, Z; Xiao, H; Yang, C; Yang, J1
Sun, Y; Tokar, EJ; Waalkes, MP1
Hayashi, R; Kato, M; Kumasaka, MY; Ohnuma, S; Shekhar, HU; Thang, ND; Watanabe, D; Yajima, I; Yanagishita, T1
Emilio, R; Mahara, V; Martín, SA1
Sun, Y; Tokar, EJ; Waalkes, MP; Xu, Y1
Barrett, JR1
Clancy, HA; Costa, M; Kluz, T; Muñoz, A; Passantino, L; Sun, H; Zavadil, J1
Acharya, S; Basu, AK; Bhattacharya, D; Chatterjee, S; Chaudhuri, S; Dasgupta, S; Flora, SJ; Kumar, P; Singh, MK1
Futscher, BW; Severson, PL; Tokar, EJ; Vrba, L; Waalkes, MP1
Perantoni, AO; Person, RJ; Sun, Y; Tokar, EJ; Waalkes, MP1
Bosland, MC; Burns, FJ; Rossman, TG; Uddin, AN1
Dong, Z1
Drobná, Z; Jaspers, I; Lin, S; Stýblo, M; Thomas, DJ1
Chiu, JF; He, QY; Li, M; Yip, TT1
Frenkel, K; Yang, C1
Bae, DS; Campain, JA; Hanneman, WH; Yang, RS1
Cotton, B; Lichtensteiger, W; Ma, R; Schlumpf, M1
Centeno, JA; Patlolla, AK; Tchounwou, PB1
Liu, KJ; Shi, H; Shi, X1
Costa, M; Huang, C; Ke, Q; Shi, X1
Benbrahim-Tallaa, L; Waalkes, MP; Webber, MM2
Chen, PH; Chiu, AW; Hsu, PY; Huang, CY; Huang, GC; Liu, HS; Tseng, YS; Tzeng, CC; Wang, YC1
Chiu, JF; Lau, AT1
Garrett, SH; Gurel, V; Park, S; Sens, DA; Sens, MA; Somji, S; Zhou, XD1
Benbrahim-Tallaa, L; Boos, J; Liu, J; Qian, X; Qu, W; Waalkes, MP; Xie, Y; Yu, L1
Chang, ZF; Kuo, YY1
Chen, Z; Chintagari, NR; Jin, N; Liu, L; Posey, T; Stricker, H; Wang, P; Weng, T1
Sirover, MA1
Chen, Z; de Thé, H; Quignon, F1
Bajenova, OV; Hamilton, JW; Ihnat, MA; Kaltreider, RC; Lariviere, JP; McCaffrey, J; Nemeth, MJ; Oh, J; Pesce, CA; Rowell, EE; Turpie, BW1
Kayajanian, GM1
An, Y; Hasegawa, A; Mizoi, M; Okada, S; Takabayashi, F; Yamanaka, K1
Bortner, CD; Hobson, MJ; Qu, W; Sakurai, T; Waalkes, MP1
Lauwerys, R1
Casto, BC; DiPaolo, JA1
Hirayama, C; Hirayoshi, K; Nagata, K; Nakai, A; Ohtsuka, K1
Sky-Peck, HH1
Bertolero, F; Pozzi, G; Sabbioni, E; Saffiotti, U1
Huang, RY; Jan, KY; Lee, TC1
Sunderman, FW1
Barrett, JC; Lee, TC; Oshimura, M1
Immich, H; Jung, EG; Traschel, B1

Reviews

29 review(s) available for arsenic and Cell Transformation, Neoplastic

ArticleYear
Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.
    The Journal of experimental medicine, 2013, Dec-16, Volume: 210, Issue:13

    Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Leukemic; Humans; Leukemia, Promyelocytic, Acute; Mice; Oncogene Proteins, Fusion; Oxides; Remission Induction; Signal Transduction; Transcriptional Activation; Tretinoin

2013
Understanding the molecular pathogenesis of acute promyelocytic leukemia.
    Best practice & research. Clinical haematology, 2014, Volume: 27, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clinical Trials as Topic; Disease Models, Animal; DNA End-Joining Repair; Drug Synergism; Granulocyte Precursor Cells; Humans; Leukemia, Promyelocytic, Acute; Mice; Molecular Targeted Therapy; Neoplasm Proteins; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Oxides; Signal Transduction; Topoisomerase II Inhibitors; Translocation, Genetic; Tretinoin

2014
Molecular insight of arsenic-induced carcinogenesis and its prevention.
    Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:5

    Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Arsenicals; Cell Transformation, Neoplastic; Chelating Agents; Dietary Supplements; DNA Damage; Environmental Exposure; Environmental Pollutants; Food Contamination; Humans; Mutation; Neoplasms; Oxidative Stress; Risk Assessment; Risk Factors; Water Pollutants, Chemical; Water Supply

2017
The impact of molecularly targeted therapies upon the understanding of leukemogenesis and the role of hematopoietic stem cell transplantation in acute promyelocytic leukemia.
    Current stem cell research & therapy, 2010, Volume: 5, Issue:4

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Survival; Cell Transformation, Neoplastic; Glutamates; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Promyelocytic, Acute; Myeloid Progenitor Cells; Neoplastic Stem Cells; Nuclear Proteins; Oxides; Prodrugs; Promyelocytic Leukemia Protein; Transcription Factors; Tretinoin; Tumor Suppressor Proteins

2010
How to manage acute promyelocytic leukemia.
    Leukemia, 2012, Volume: 26, Issue:8

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Transformation, Neoplastic; Central Nervous System Neoplasms; Consolidation Chemotherapy; Drug Synergism; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Oxides; Recurrence; Tretinoin

2012
Hypoxia inducible factor-1alpha and leukemic cell differentiation.
    Sheng li xue bao : [Acta physiologica Sinica], 2006, Feb-25, Volume: 58, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Transformation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Leukemia; Leukemia, Promyelocytic, Acute; Oxides

2006
Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
    Toxicology, 2008, Jun-27, Volume: 248, Issue:2-3

    Topics: Animals; Arsenicals; Carcinogens; Carcinoma, Transitional Cell; Cell Line, Transformed; Cell Transformation, Neoplastic; Humans; Models, Biological; Urinary Bladder Neoplasms; Urothelium

2008
The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects.
    Critical reviews in oncology/hematology, 2002, Volume: 42, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic; Arsenicals; Cell Transformation, Neoplastic; Glutathione; Humans; MAP Kinase Signaling System; Mice; Neoplasms; Neoplasms, Experimental; NF-kappa B; Transcription Factor AP-1; Transcription, Genetic

2002
Metabolic reprogramming in the arsenic carcinogenesis.
    Ecotoxicology and environmental safety, 2022, Jan-01, Volume: 229

    Topics: Arsenic; Carcinogenesis; Cell Transformation, Neoplastic; Glycolysis; Humans; Neoplasms; Tumor Microenvironment

2022
Tumor suppressive activity of AHR in environmental arsenic-induced carcinogenesis.
    Toxicology and applied pharmacology, 2023, Dec-01, Volume: 480

    Topics: Arsenic; Carcinogenesis; Cell Transformation, Neoplastic; Humans; NF-E2-Related Factor 2; Receptors, Aryl Hydrocarbon

2023
Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development.
    Environmental research, 2019, Volume: 178

    Topics: Arsenic; Breast Neoplasms; Cadmium; Cell Transformation, Neoplastic; Environmental Exposure; Environmental Pollutants; Humans; Male; Metals, Heavy; Prostatic Neoplasms

2019
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

2016
Cooperation between NRF2-mediated transcription and MDIG-dependent epigenetic modifications in arsenic-induced carcinogenesis and cancer stem cells.
    Seminars in cancer biology, 2021, Volume: 76

    Topics: Animals; Arsenic; Cell Transformation, Neoplastic; Dioxygenases; Epigenesis, Genetic; Histone Demethylases; Humans; Neoplastic Stem Cells; NF-E2-Related Factor 2; Nuclear Proteins; Transcription, Genetic

2021
A comprehensive review of metal-induced cellular transformation studies.
    Toxicology and applied pharmacology, 2017, 09-15, Volume: 331

    Topics: Animals; Apoptosis; Arsenic; Carcinogens; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Metals; Nickel

2017
Arsenic toxicity and epimutagenecity: the new LINEage.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2017, Volume: 30, Issue:4

    Topics: Arsenic; Arsenic Poisoning; Cell Transformation, Neoplastic; CpG Islands; DNA Methylation; Environmental Exposure; Epigenesis, Genetic; Folic Acid; Genome, Human; Humans; Long Interspersed Nucleotide Elements; Neoplasms; Promoter Regions, Genetic; S-Adenosylmethionine

2017
Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation.
    Toxicological sciences : an official journal of the Society of Toxicology, 2018, 10-01, Volume: 165, Issue:2

    Topics: Arsenic; Carcinogenesis; Cell Transformation, Neoplastic; Epigenesis, Genetic; Humans; MicroRNAs; Neoplasms; Water Pollutants, Chemical

2018
Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells.
    Seminars in cancer biology, 2019, Volume: 57

    Topics: Animals; Arsenic; Autophagy; Cell Transformation, Neoplastic; Cellular Reprogramming; Disease Susceptibility; Endoplasmic Reticulum Stress; Energy Metabolism; Epigenesis, Genetic; Gene Expression Regulation; Humans; Metabolic Networks and Pathways; Mitochondria; Neoplasms; Neoplastic Stem Cells; Signal Transduction

2019
Metal-induced carcinogenesis, oxidative stress and hypoxia signalling.
    Mutation research, 2009, Mar-31, Volume: 674, Issue:1-2

    Topics: Animals; Arsenic; Carcinogens, Environmental; Cell Hypoxia; Cell Transformation, Neoplastic; Humans; Metals, Heavy; Models, Biological; Oxidative Stress; Reactive Oxygen Species; Signal Transduction

2009
Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium.
    Metallomics : integrated biometal science, 2009, Volume: 1, Issue:3

    Topics: Animals; Arsenic; Arsenic Poisoning; Cell Transformation, Neoplastic; DNA Methylation; Epigenomics; Gene Expression Regulation, Neoplastic; Heavy Metal Poisoning; Humans; Metals, Heavy

2009
The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update.
    Environmental health perspectives, 2002, Volume: 110 Suppl 5

    Topics: Animals; Arsenic; Biotransformation; Cell Line; Cell Transformation, Neoplastic; Humans; Mammals; Methylation; Methyltransferases; Transcription, Genetic

2002
Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2002, Volume: 21, Issue:4

    Topics: Arsenic; Cell Transformation, Neoplastic; DNA-Binding Proteins; Environmental Pollutants; Gene Expression Regulation, Neoplastic; Humans; Mitogen-Activated Protein Kinases; NF-kappa B; Replication Protein C; Signal Transduction

2002
Arsenic toxicity, mutagenesis, and carcinogenesis--a health risk assessment and management approach.
    Molecular and cellular biochemistry, 2004, Volume: 255, Issue:1-2

    Topics: Arsenic; Arsenic Poisoning; Carcinogens, Environmental; Cell Transformation, Neoplastic; Environmental Exposure; Environmental Health; Environmental Monitoring; Humans; Mutagenesis; Primary Prevention; Risk Assessment; Skin Neoplasms; Water Pollutants, Chemical

2004
Oxidative mechanism of arsenic toxicity and carcinogenesis.
    Molecular and cellular biochemistry, 2004, Volume: 255, Issue:1-2

    Topics: Animals; Antioxidants; Arsenic; Cattle; Cell Transformation, Neoplastic; Cricetinae; DNA Damage; Free Radical Scavengers; Free Radicals; Gene Expression Regulation, Neoplastic; Humans; Lipid Peroxidation; Mice; Neoplasms; Oxidative Stress; Rats; Reactive Oxygen Species; Tumor Suppressor Protein p53

2004
Molecular mechanisms of arsenic carcinogenesis.
    Molecular and cellular biochemistry, 2004, Volume: 255, Issue:1-2

    Topics: Animals; Arsenic; Cell Transformation, Neoplastic; Cricetinae; Cytokines; DNA Damage; DNA Repair; Environmental Pollutants; Gene Expression Regulation, Neoplastic; Humans; Mice; Mutagens; Oncogenes; Oxidative Stress; Protein Kinases; Rabbits; Rats; Reactive Oxygen Species; Signal Transduction; Transcription Factors

2004
Signal transduction pathways in cancer development and as targets for cancer prevention.
    Progress in nucleic acid research and molecular biology, 2005, Volume: 79

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Arsenic; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Design; Histones; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Neoplasms; Phosphorylation; Protein Kinase C; Signal Transduction; Transcription Factors; Ultraviolet Rays

2005
Effects of metals in in vitro bioassays.
    Environmental health perspectives, 1981, Volume: 40

    Topics: Animals; Arsenic; Biological Assay; Cell Transformation, Neoplastic; Cell Transformation, Viral; Chromium; Chromosome Aberrations; Cricetinae; Humans; Mesocricetus; Metals; Mutagenicity Tests; Neoplasms; Platinum; Selenium

1981
Retinoic acid and arsenic: towards oncogene-targeted treatments of acute promyelocytic leukaemia.
    Biochimica et biophysica acta, 1997, Dec-09, Volume: 1333, Issue:3

    Topics: Animals; Arsenic; Artificial Gene Fusion; Cell Transformation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Nuclear Proteins; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Transcription Factors; Translocation, Genetic; Tretinoin; Tumor Suppressor Proteins

1997
[Occupational chemical pollution and cancer].
    Archives belges de medecine sociale, hygiene, medecine du travail et medecine legale. Belgisch archief van sociale geneeskunde, hygiene, arbeidsgeneeskunde en gerechtelijke geneeskunde, 1979, Volume: 37, Issue:6

    Topics: Acrylonitrile; Animals; Arsenic; Asbestosis; Belgium; Benzene Derivatives; Biotransformation; Cadmium; Carcinogens; Cell Transformation, Neoplastic; Chemical Industry; Epoxy Compounds; Humans; Hydrocarbons, Halogenated; Mice; Mining; Neoplasms; Nickel; Nitroso Compounds; Occupational Diseases; Textile Industry; United States

1979
Trace metals and neoplasia.
    Clinical physiology and biochemistry, 1986, Volume: 4, Issue:1

    Topics: Animals; Arsenic; Beryllium; Cadmium; Carcinogens; Cell Transformation, Neoplastic; Chromium; Chromosome Aberrations; DNA; DNA Polymerase I; Environmental Exposure; Gastrointestinal Neoplasms; Humans; In Vitro Techniques; Neoplasms; Neoplasms, Experimental; Nickel; Occupational Diseases; Respiratory Tract Neoplasms; Selenium; Trace Elements

1986

Trials

1 trial(s) available for arsenic and Cell Transformation, Neoplastic

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

2016

Other Studies

145 other study(ies) available for arsenic and Cell Transformation, Neoplastic

ArticleYear
DNA methylation of a non-CpG island promoter represses NQO1 expression in rat arsenic-transformed lung epithelial cells.
    Acta biochimica et biophysica Sinica, 2018, Aug-01, Volume: 50, Issue:8

    Topics: Animals; Arsenic Trioxide; Arsenicals; Azacitidine; Cell Line, Transformed; Cell Transformation, Neoplastic; CpG Islands; Decitabine; DNA Methylation; Enzyme Inhibitors; Epithelial Cells; Gene Expression Regulation; Lung; NAD(P)H Dehydrogenase (Quinone); Oxides; Promoter Regions, Genetic; Rats

2018
Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Glia, 2013, Volume: 61, Issue:9

    Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formazans; Gene Expression Regulation, Neoplastic; Glioma; Glycoproteins; GTPase-Activating Proteins; Homeodomain Proteins; Humans; Intercellular Signaling Peptides and Proteins; Lentivirus; Oncogene Protein v-akt; Oxides; Peptides; Rats; Rats, Sprague-Dawley; Receptor, Notch1; RNA, Messenger; RNA, Small Interfering; Tetrazolium Salts; Time Factors; Transcription Factor HES-1; Transfection; Tumor Stem Cell Assay

2013
Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha.
    International journal of cancer, 2014, Feb-15, Volume: 134, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzamides; Bone Marrow Transplantation; Cell Transformation, Neoplastic; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Oxides; Piperazines; Prognosis; Pyrimidines; Real-Time Polymerase Chain Reaction; Survival Rate; Tumor Cells, Cultured; Tumor Stem Cell Assay

2014
Methylarsonous acid causes oxidative DNA damage in cells independent of the ability to biomethylate inorganic arsenic.
    Archives of toxicology, 2014, Volume: 88, Issue:2

    Topics: Adaptation, Physiological; Animals; Arsenic Poisoning; Arsenicals; Cell Line; Cell Transformation, Neoplastic; DNA Damage; Humans; Liver; Male; Methylation; Multidrug Resistance-Associated Protein 2; Oxidation-Reduction; Prostate; PTEN Phosphohydrolase; Rats; Toxicity Tests, Chronic

2014
The acute promyelocytic leukaemia success story: curing leukaemia through targeted therapies.
    Journal of internal medicine, 2014, Volume: 276, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Transformation, Neoplastic; Epigenesis, Genetic; Humans; Leukemia, Promyelocytic, Acute; Molecular Targeted Therapy; Oxides; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoid X Receptor alpha; Signal Transduction; Tretinoin

2014
Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
    Blood, 2014, Dec-11, Volume: 124, Issue:25

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Line, Tumor; Cell Transformation, Neoplastic; Cells, Cultured; Chlorocebus aethiops; COS Cells; Gene Expression Profiling; Humans; Leukemia, Promyelocytic, Acute; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Nude; Mice, Transgenic; Oncogene Proteins, Fusion; Oxides; Promoter Regions, Genetic; Protein Binding; Retinoid X Receptor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sumoylation; Transcriptional Activation; Tretinoin

2014
TG-interacting factor mediates arsenic-induced malignant transformation of keratinocytes via c-Src/EGFR/AKT/FOXO3A and redox signalings.
    Archives of toxicology, 2015, Volume: 89, Issue:12

    Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Line; Cell Transformation, Neoplastic; CSK Tyrosine-Protein Kinase; Dose-Response Relationship, Drug; ErbB Receptors; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Knockdown Techniques; Homeodomain Proteins; Humans; Keratinocytes; Mice; NIH 3T3 Cells; Oxidation-Reduction; Oxides; Proto-Oncogene Proteins c-akt; Repressor Proteins; Signal Transduction; src-Family Kinases

2015
Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic.
    Oncotarget, 2015, Aug-28, Volume: 6, Issue:25

    Topics: Amino Acid Motifs; Arsenic Trioxide; Arsenicals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinogenesis; Cell Line; Cell Transformation, Neoplastic; Computational Biology; DNA Methylation; Gene Expression Regulation, Neoplastic; Hepatocytes; Humans; Liver; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Oxides; Promoter Regions, Genetic; RNA, Messenger; Signal Transduction; Transcription Factors; Transcriptional Activation; Wnt Proteins

2015
Dimethylarsine likely acts as a mouse-pulmonary tumor initiator via the production of dimethylarsine radical and/or its peroxy radical.
    Life sciences, 2009, Apr-24, Volume: 84, Issue:17-18

    Topics: Animals; Arsenicals; Carcinogens; Cell Transformation, Neoplastic; Glutathione Reductase; Lung; Lung Neoplasms; Male; Mice; Peroxides; Rats

2009
Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells.
    Cell biology international, 2008, Volume: 32, Issue:12

    Topics: Antineoplastic Agents; Arsenicals; CD11 Antigens; Cell Differentiation; Cell Transformation, Neoplastic; HL-60 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia, Promyelocytic, Acute; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Nanoparticles; p38 Mitogen-Activated Protein Kinases; RNA, Messenger; Sulfides

2008
Antitumor effects of arsenic trioxide in transformed human thyroid cells.
    Thyroid : official journal of the American Thyroid Association, 2008, Volume: 18, Issue:11

    Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Biological Transport, Active; Carcinoma, Papillary; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Glucose; Glutathione; Humans; Iodides; Iodine Radioisotopes; Oncogene Protein v-akt; Oxides; Phosphatidylinositol 3-Kinases; Radiation Tolerance; Reactive Oxygen Species; Thyroid Neoplasms

2008
Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation.
    Toxicology and applied pharmacology, 2009, Feb-15, Volume: 235, Issue:1

    Topics: Arsenicals; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Epigenesis, Genetic; Gene Silencing; Histones; Humans; Mutation; Promoter Regions, Genetic; Proto-Oncogene Proteins; Transcription, Genetic; Wnt Proteins; Wnt-5a Protein

2009
Comparison of sensitivity to arsenic compounds between a Bhas 42 cell transformation assay and a BALB/c 3T3 cell transformation assay.
    Mutation research, 2009, Apr-30, Volume: 675, Issue:1-2

    Topics: Animals; Arsenates; Arsenicals; Arsenites; BALB 3T3 Cells; Cacodylic Acid; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Mice

2009
Arsenic and prostate cancer.
    Harvard men's health watch, 2009, Volume: 14, Issue:1

    Topics: Arsenicals; Biomarkers; Cell Transformation, Neoplastic; Environmental Exposure; Erectile Dysfunction; Humans; Male; Prostate; Prostatic Neoplasms; United States; Water Pollution, Chemical; Water Supply

2009
Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.
    Journal of applied toxicology : JAT, 2010, Volume: 30, Issue:5

    Topics: Animals; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Carcinogens; Carcinoma, Transitional Cell; Cell Line, Transformed; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Keratin-6; Mice; Mice, Nude; Neoplasm Transplantation; Oxides; Urinary Bladder Neoplasms; Urothelium

2010
Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting.
    International journal of hematology, 2010, Volume: 91, Issue:5

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Granulocyte Precursor Cells; Humans; Leukemia, Promyelocytic, Acute; Mice; Oncogene Proteins, Fusion; Oncogenes; Oxides; Tretinoin

2010
Arsenic, stem cells, and the developmental basis of adult cancer.
    Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 120 Suppl 1

    Topics: Animals; Arsenic Poisoning; Arsenicals; Carcinogenicity Tests; Carcinogens, Environmental; Cell Transformation, Neoplastic; Epigenesis, Genetic; Female; Humans; Maternal Exposure; Maternal-Fetal Exchange; Mice; Neoplastic Stem Cells; Pregnancy; Prenatal Exposure Delayed Effects; Skin Neoplasms; Water Pollutants, Chemical

2011
miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis.
    Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 123, Issue:2

    Topics: Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Bronchi; Carcinogens, Environmental; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Down-Regulation; Epithelial Cells; Gene Expression Regulation; Gene Silencing; Humans; MicroRNAs; Nuclear Proteins; Oxides; Phosphoprotein Phosphatases; RNA, Messenger; Talin

2011
Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 339, Issue:2

    Topics: 8,11,14-Eicosatrienoic Acid; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Transformation, Neoplastic; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; HEK293 Cells; Humans; Indazoles; Membrane Potential, Mitochondrial; Mitochondria; Nitrofurans; Oxides; Reactive Oxygen Species

2011
Reactive oxygen species mediate arsenic induced cell transformation and tumorigenesis through Wnt/β-catenin pathway in human colorectal adenocarcinoma DLD1 cells.
    Toxicology and applied pharmacology, 2011, Oct-15, Volume: 256, Issue:2

    Topics: Adenocarcinoma; Animals; Arsenicals; beta Catenin; Blotting, Western; Carcinogenicity Tests; Catenins; Cell Line, Tumor; Cell Transformation, Neoplastic; Colorectal Neoplasms; Electron Spin Resonance Spectroscopy; Enzyme Activation; Humans; Male; Mice; Mice, Nude; NADPH Oxidases; Reactive Oxygen Species; Signal Transduction; Wnt Proteins

2011
The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.
    Cancer research, 2012, May-01, Volume: 72, Issue:9

    Topics: Animals; Arsenic Trioxide; Arsenicals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; HEK293 Cells; Humans; Lung Neoplasms; Nuclear Proteins; Oncogene Proteins, Fusion; Oxides; Polymorphism, Single Nucleotide; Promyelocytic Leukemia Protein; Protein Inhibitors of Activated STAT; Rats; Small Ubiquitin-Related Modifier Proteins; Transcription Factors; Transfection; Tumor Suppressor Proteins; Ubiquitin

2012
Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells.
    Toxicology and applied pharmacology, 2012, Jun-01, Volume: 261, Issue:2

    Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Epithelial Cells; Female; Gene Regulatory Networks; Humans; Lung; Lung Neoplasms; Mice; Mitochondria; Neoplasm Invasiveness; Occupational Exposure; Oligonucleotide Array Sequence Analysis; Oxides; PPAR alpha; Signal Transduction

2012
Polycomb (PcG) proteins, BMI1 and SUZ12, regulate arsenic-induced cell transformation.
    The Journal of biological chemistry, 2012, Sep-14, Volume: 287, Issue:38

    Topics: 3T3 Cells; Animals; Arsenic; Arsenic Trioxide; Arsenicals; Cell Transformation, Neoplastic; Cyclin-Dependent Kinase Inhibitor p16; Gene Expression Regulation, Neoplastic; Histones; Humans; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oxides; Polycomb Repressive Complex 1; Polycomb Repressive Complex 2; Polycomb-Group Proteins; Proto-Oncogene Proteins; Signal Transduction

2012
The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability.
    Oncogene, 2013, Oct-24, Volume: 32, Issue:43

    Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Transformation, Neoplastic; Endopeptidases; Gene Expression Regulation, Leukemic; Humans; Leukemia, Promyelocytic, Acute; Mice; Oncogene Proteins, Fusion; Oxides; Protein Stability; Translocation, Genetic

2013
Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.
    Molecular carcinogenesis, 2014, Volume: 53, Issue:5

    Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Dose-Response Relationship, Drug; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Lung; Lung Neoplasms; Mice; Mice, SCID; Oxides; Polymorphism, Single Nucleotide; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering

2014
Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells.
    Toxicological sciences : an official journal of the Society of Toxicology, 2004, Volume: 79, Issue:1

    Topics: Agar; Animals; Arsenicals; Cadmium Compounds; Cell Culture Techniques; Cell Division; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Time Factors; Urinary Bladder; Urothelium

2004
A trivalent dimethylarsenic compound, dimethylarsine iodide, induces cellular transformation, aneuploidy, centrosome abnormality and multipolar spindle formation in Syrian hamster embryo cells.
    Toxicology, 2004, Oct-15, Volume: 203, Issue:1-3

    Topics: Aneuploidy; Animals; Arsenicals; Cell Division; Cell Transformation, Neoplastic; Centrosome; Cricetinae; DNA; Flow Cytometry; Fluorescent Antibody Technique; Mesocricetus; Microtubules; Precancerous Conditions; Spindle Apparatus

2004
Inorganic arsenic compounds and methylated metabolites induce morphological transformation in two-stage BALB/c 3T3 cell assay and inhibit metabolic cooperation in V79 cell assay.
    Toxicological sciences : an official journal of the Society of Toxicology, 2005, Volume: 84, Issue:2

    Topics: Animals; Arsenic Poisoning; Arsenicals; BALB 3T3 Cells; Cacodylic Acid; Carcinogens; Cell Communication; Cell Survival; Cell Transformation, Neoplastic; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Methylcholanthrene; Mice; Sulfhydryl Reagents

2005
Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.
    British journal of haematology, 2005, Volume: 128, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Bryostatins; Cell Cycle; Cell Line, Tumor; Cell Transformation, Neoplastic; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Macrolides; Myelopoiesis; Oxides; Tretinoin

2005
Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxide-induced apoptosis.
    Cancer biology & therapy, 2005, Volume: 4, Issue:4

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Caspase 3; Caspases; Cell Line, Transformed; Cell Transformation, Neoplastic; Cells, Cultured; Cytochrome c Group; Dose-Response Relationship, Drug; Embryo, Mammalian; Fibroblasts; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Mitochondria, Liver; Necrosis; Oxidative Stress; Oxides; Reactive Oxygen Species; Superoxides

2005
Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis.
    Leukemia research, 2008, Volume: 32, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Blotting, Western; Camptothecin; Caspases; Cell Line, Transformed; Cell Transformation, Neoplastic; Chickens; Cycloheximide; Genes, myb; Humans; Microscopy, Fluorescence; Necrosis; Oxides; Signal Transduction; U937 Cells

2008
Epigenetic remodeling during arsenical-induced malignant transformation.
    Carcinogenesis, 2008, Volume: 29, Issue:8

    Topics: Acetylation; Arsenicals; Azacitidine; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Decitabine; Environmental Exposure; Histones; Humans; Hydroxamic Acids; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Teratogens; Urinary Bladder Neoplasms; Urothelium

2008
[Dynamics of nickel in the cell].
    Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete, 1984, Volume: 30, Issue:11

    Topics: Animals; Arsenicals; Cell Transformation, Neoplastic; Humans; Mitosis; Nickel

1984
[Double effects of arsenic trioxide (As2O3) on acute promyelocytic leukemic cell line].
    Zhonghua yi xue za zhi, 1997, Volume: 77, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Transformation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Oxides; Tumor Cells, Cultured

1997
Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia.
    Journal of the National Cancer Institute, 1998, Dec-16, Volume: 90, Issue:24

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Differentiation; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Promyelocytic, Acute; Oxides; Tretinoin; Tumor Cells, Cultured

1998
Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis.
    Biochemical and biophysical research communications, 1999, Sep-24, Volume: 263, Issue:2

    Topics: Arsenates; Arsenic; Arsenic Poisoning; Arsenicals; Arsenites; Cell Line; Cell Transformation, Neoplastic; Humans; Keratinocytes; Nuclear Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Teratogens; Tumor Suppressor Protein p53

1999
[Cell differentiation and apoptosis of tumor cells].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 1999, Volume: 19, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Transformation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Oxides

1999
[Affect of As(2)O(3) on the sister chromatid exchanges in human blood lymphocytes].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2001, Volume: 22, Issue:7

    Topics: Arsenicals; Carcinogens; Cell Cycle; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Lymphocytes; Sister Chromatid Exchange

2001
[Comment on the short report by H. Krause and E.-I. Grussendorf: Syntopy of Bowen disease and mustard gas scar].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1992, Volume: 43, Issue:1

    Topics: Aged; Arsenicals; Bowen's Disease; Burns, Chemical; Cell Transformation, Neoplastic; Cicatrix; Humans; Male; Mustard Gas; Skin; Skin Neoplasms

1992
Cellular retention, toxicity and carcinogenic potential of seafood arsenic. I. Lack of cytotoxicity and transforming activity of arsenobetaine in the BALB/3T3 cell line.
    Carcinogenesis, 1991, Volume: 12, Issue:7

    Topics: Animals; Arsenic; Arsenic Poisoning; Arsenicals; Biotransformation; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Food Contamination; Mice

1991
Clinical cancer chemotherapy aimed at cellular control mechanisms.
    IMJ. Illinois medical journal, 1970, Volume: 137, Issue:3

    Topics: Adult; Antineoplastic Agents; Arsenicals; Cell Transformation, Neoplastic; Culture Techniques; Female; Humans; Hyperbaric Oxygenation; Iodoacetates; Male; Middle Aged; Neoplasms

1970
Metabolomic dynamics of the arsenic-transformed bronchial epithelial cells and the derived cancer stem-like cells.
    International journal of biological sciences, 2022, Volume: 18, Issue:1

    Topics: Arsenic; Bronchi; Carcinogens, Environmental; Cell Line, Tumor; Cell Transformation, Neoplastic; Epithelial Cells; Humans; Metabolic Networks and Pathways; Metabolomics; Neoplastic Stem Cells

2022
Arsenic activates STAT3 signaling during the transformation of the human bronchial epithelial cells.
    Toxicology and applied pharmacology, 2022, 02-01, Volume: 436

    Topics: Apoptosis Regulatory Proteins; Arsenic; Bronchi; Carcinogenesis; Cell Transformation, Neoplastic; Cells, Cultured; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Phosphorylation; Reactive Oxygen Species; RNA-Binding Proteins; Signal Transduction; STAT3 Transcription Factor

2022
The Potential Key Role of the NRF2/NQO1 Pathway in the Health Effects of Arsenic Pollution on SCC.
    International journal of environmental research and public health, 2022, 07-01, Volume: 19, Issue:13

    Topics: Arsenic; Arsenites; Cell Line; Cell Transformation, Neoplastic; Cyclin E; Humans; Keratinocytes; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; RNA, Small Interfering

2022
A Comprehensive Transcriptomic Analysis of Arsenic-Induced Bladder Carcinogenesis.
    Cells, 2022, 08-05, Volume: 11, Issue:15

    Topics: Arsenic; Cell Transformation, Neoplastic; Humans; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases; Transcriptome; Urinary Bladder

2022
As-Cd-Pb Mixture Induces Cellular Transformation via Post-Transcriptional Regulation of Rad51c by miR-222.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2019, Volume: 53, Issue:6

    Topics: Animals; Antagomirs; Arsenic; BALB 3T3 Cells; Cadmium; Cell Survival; Cell Transformation, Neoplastic; DNA Breaks, Double-Stranded; DNA-Binding Proteins; Gene Expression Regulation; Lead; Metals, Heavy; Mice; MicroRNAs; Rad51 Recombinase

2019
Enhanced p62-NRF2 Feedback Loop due to Impaired Autophagic Flux Contributes to Arsenic-Induced Malignant Transformation of Human Keratinocytes.
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Arsenic; Autophagic Cell Death; Cell Line; Cell Transformation, Neoplastic; Feedback, Physiological; Humans; Keratinocytes; Mechanistic Target of Rapamycin Complex 1; Neoplasm Proteins; NF-E2-Related Factor 2; Proteolysis; RNA-Binding Proteins; RNA, Neoplasm; Signal Transduction

2019
Epigenetic regulations in alternative telomere lengthening: Understanding the mechanistic insight in arsenic-induced skin cancer patients.
    The Science of the total environment, 2020, Feb-20, Volume: 704

    Topics: Arsenic; Carcinogenesis; Cell Transformation, Neoplastic; DNA Methylation; Epigenesis, Genetic; Humans; Skin Neoplasms; Telomerase; Telomere; Telomere Homeostasis

2020
Characterization of Arsenic-Induced Cancer Stem-Like Cells.
    Methods in molecular biology (Clifton, N.J.), 2020, Volume: 2117

    Topics: Arsenic; Bronchi; Cell Dedifferentiation; Cell Line; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Neoplastic Stem Cells; Proto-Oncogene Proteins c-myc; Up-Regulation

2020
Arsenic and benzo[a]pyrene co-exposure acts synergistically in inducing cancer stem cell-like property and tumorigenesis by epigenetically down-regulating SOCS3 expression.
    Environment international, 2020, Volume: 137

    Topics: Animals; Arsenic; Benzo(a)pyrene; Carcinogenesis; Carcinogens, Environmental; Cell Transformation, Neoplastic; Down-Regulation; Epigenesis, Genetic; Female; Humans; Male; Mice; Neoplastic Stem Cells; Suppressor of Cytokine Signaling 3 Protein

2020
Effects of Inorganic Arsenic on Human Prostate Stem-Progenitor Cell Transformation, Autophagic Flux Blockade, and NRF2 Pathway Activation.
    Environmental health perspectives, 2020, Volume: 128, Issue:6

    Topics: Animals; Arsenic; Cell Line; Cell Transformation, Neoplastic; Hazardous Substances; Humans; Male; Mice; Mice, Nude; NF-E2-Related Factor 2; Prostate; Rats; Stem Cells

2020
Autophagy mediates bronchial cell malignant transformation induced by chronic arsenic exposure via MEK/ERK1/2 pathway.
    Toxicology letters, 2020, Oct-10, Volume: 332

    Topics: Arsenic; Autophagy; Beclin-1; Bronchi; Bronchial Neoplasms; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Epithelial-Mesenchymal Transition; Humans; Inflammasomes; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Signal Transduction; Wound Healing

2020
Integrin α4 up-regulation activates the hedgehog pathway to promote arsenic and benzo[α]pyrene co-exposure-induced cancer stem cell-like property and tumorigenesis.
    Cancer letters, 2020, 11-28, Volume: 493

    Topics: Animals; Arsenic; Benzo(a)pyrene; Cell Line; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Integrin alpha4; Lung Neoplasms; Mice; Neoplastic Stem Cells; Protein Stability; Repressor Proteins; Signal Transduction; Up-Regulation

2020
FRA1 is essential for the maintenance of the oncogenic phenotype induced by
    Metallomics : integrated biometal science, 2020, 12-23, Volume: 12, Issue:12

    Topics: Animals; Arsenic; Carcinogenesis; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Mice; Proto-Oncogene Proteins c-fos; Up-Regulation

2020
Arsenic as an environmental toxicant and a therapeutic agent: Foe and friend.
    Toxicology and applied pharmacology, 2021, 03-15, Volume: 415

    Topics: Animals; Antineoplastic Agents; Arsenic; Arsenic Poisoning; Cell Transformation, Neoplastic; DNA Damage; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Nervous System; Patient Safety; Risk Assessment; Risk Factors

2021
Autophagy of the m
    Nature communications, 2021, 04-12, Volume: 12, Issue:1

    Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Arsenic; Autophagy; Base Sequence; Carcinogenesis; Cell Transformation, Neoplastic; Down-Regulation; Epidermis; Gene Ontology; HaCaT Cells; HEK293 Cells; Humans; Keratinocytes; Lysosomes; Mice; Nedd4 Ubiquitin Protein Ligases; NF-kappa B; Protein Stability; RNA Stability; RNA, Messenger; Sequestosome-1 Protein; Transcriptome; Tumor Necrosis Factor-alpha; Up-Regulation; Vacuoles

2021
M2 polarization of macrophages facilitates arsenic-induced cell transformation of lung epithelial cells.
    Oncotarget, 2017, Mar-28, Volume: 8, Issue:13

    Topics: Arsenic; Blotting, Western; Cell Differentiation; Cell Transformation, Neoplastic; Cells, Cultured; Coculture Techniques; Flow Cytometry; Humans; Lung Neoplasms; Macrophage Activation; Real-Time Polymerase Chain Reaction; Respiratory Mucosa

2017
Long-term exposure of immortalized keratinocytes to arsenic induces EMT, impairs differentiation in organotypic skin models and mimics aspects of human skin derangements.
    Archives of toxicology, 2018, Volume: 92, Issue:1

    Topics: Animals; Arsenic; Arsenic Trioxide; Cell Culture Techniques; Cell Differentiation; Cell Transformation, Neoplastic; Epithelial-Mesenchymal Transition; Female; Humans; Keratinocytes; Mice, Inbred Strains; Organ Culture Techniques; Skin; Toxicity Tests, Chronic; Xenograft Model Antitumor Assays

2018
Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial -mesenchymal transition.
    Cancer biology & therapy, 2017, Dec-02, Volume: 18, Issue:12

    Topics: Animals; Arsenic; Bronchi; Carcinogenesis; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Epithelial Cells; Epithelial-Mesenchymal Transition; Heterografts; Humans; Mice; MicroRNAs; Signal Transduction

2017
Flavonoids inhibit chronically exposed arsenic-induced proliferation and malignant transformation of HaCaT cells.
    Photodermatology, photoimmunology & photomedicine, 2018, Volume: 34, Issue:1

    Topics: Antioxidants; Arsenic; Cell Line; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Flavonoids; Flavonols; Gamma Rays; Gene Expression; Humans; Intercellular Signaling Peptides and Proteins; Keratinocytes; Minor Histocompatibility Antigens; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; rab GTP-Binding Proteins; Silybin; Silymarin; Tenascin

2018
Selective inhibition of CTCF binding by iAs directs TET-mediated reprogramming of 5-hydroxymethylation patterns in iAs-transformed cells.
    Toxicology and applied pharmacology, 2018, 01-01, Volume: 338

    Topics: 5-Methylcytosine; Arsenic; CCCTC-Binding Factor; Cell Transformation, Neoplastic; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Humans; Mixed Function Oxygenases; Promoter Regions, Genetic; Proto-Oncogene Proteins

2018
Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells.
    International journal of cancer, 2018, 07-01, Volume: 143, Issue:1

    Topics: Arsenic; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cyclooxygenase 2; Dinoprostone; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoplastic Stem Cells; SOXB1 Transcription Factors; Up-Regulation; Urothelium

2018
Role of miR-31 and SATB2 in arsenic-induced malignant BEAS-2B cell transformation.
    Molecular carcinogenesis, 2018, Volume: 57, Issue:8

    Topics: Arsenic; Carcinogenesis; Carcinogens; Cell Adhesion Molecules, Neuronal; Cell Line; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MicroRNAs; RNA, Messenger

2018
[Effect of low-dose exposure to sodium arsenite on proliferation of HBE and HaCaT cells].
    Wei sheng yan jiu = Journal of hygiene research, 2017, Volume: 46, Issue:1

    Topics: Arsenic; Arsenites; Cell Cycle; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Cyclin D1; Epithelial Cells; Humans; Keratinocytes; Sodium Compounds; Up-Regulation

2017
Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype.
    Toxicological sciences : an official journal of the Society of Toxicology, 2018, 09-01, Volume: 165, Issue:1

    Topics: Arsenic; Cell Line, Tumor; Cell Transformation, Neoplastic; Environmental Pollutants; Epithelial Cells; Exosomes; Gene Expression; Humans; Male; Neoplastic Stem Cells; Prostate; Proto-Oncogene Proteins p21(ras); Signal Transduction

2018
Malignant Transformation of Human Bronchial Epithelial Cells Induced by Arsenic through STAT3/miR-301a/SMAD4 Loop.
    Scientific reports, 2018, 09-05, Volume: 8, Issue:1

    Topics: Apoptosis; Arsenic; Bronchi; Carcinogenesis; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MicroRNAs; Neoplasms; Reactive Oxygen Species; Signal Transduction; Smad4 Protein; STAT3 Transcription Factor

2018
Long-Term Combinatorial Exposure to Trichloroethylene and Inorganic Arsenic in Genetically Heterogeneous Mice Results in Renal Tubular Damage and Cancer-Associated Molecular Changes.
    G3 (Bethesda, Md.), 2019, 05-07, Volume: 9, Issue:5

    Topics: Animals; Arsenic; Biomarkers; Cell Transformation, Neoplastic; Disease Models, Animal; Drug Synergism; Environmental Exposure; Genetic Predisposition to Disease; Kaplan-Meier Estimate; Kidney Function Tests; Kidney Neoplasms; Kidney Tubules; Male; Mice; Mice, Transgenic; Mutation; Prognosis; Trichloroethylene; Von Hippel-Lindau Tumor Suppressor Protein

2019
Exposure of low-concentration arsenic-initiated inflammation and autophagy in rat lungs.
    Journal of biochemical and molecular toxicology, 2019, Volume: 33, Issue:7

    Topics: Animals; Arsenic; Autophagy; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Inflammation; Lung; Lung Neoplasms; Male; Pneumonia; Rats; Rats, Sprague-Dawley

2019
Arsenic-Induced Neoplastic Transformation Involves Epithelial-Mesenchymal Transition and Activation of the β-Catenin/c-Myc Pathway in Human Kidney Epithelial Cells.
    Chemical research in toxicology, 2019, 06-17, Volume: 32, Issue:6

    Topics: Arsenic; beta Catenin; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Proto-Oncogene Proteins c-myc

2019
Analysis of the dynamic aberrant landscape of DNA methylation and gene expression during arsenic-induced cell transformation.
    Gene, 2019, Aug-30, Volume: 711

    Topics: Animals; Arsenic; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Transplantation; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Skin Neoplasms

2019
Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies.
    The Journal of experimental medicine, 2013, Apr-08, Volume: 210, Issue:4

    Topics: Animals; Antineoplastic Agents; Arsenic; Cell Differentiation; Cell Line; Cell Transformation, Neoplastic; Gene Expression Regulation, Leukemic; Humans; Leukemia, Promyelocytic, Acute; Mice; Nuclear Proteins; Promyelocytic Leukemia Protein; Proteolysis; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Transcription Factors; Transcriptional Activation; Tretinoin; Tumor Suppressor Proteins

2013
CD44v6 expression in human skin keratinocytes as a possible mechanism for carcinogenesis associated with chronic arsenic exposure.
    European journal of histochemistry : EJH, 2013, Jan-14, Volume: 57, Issue:1

    Topics: Animals; Arsenic; Arsenites; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Enzyme Inhibitors; Humans; Hyaluronan Receptors; Keratinocytes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplastic Stem Cells; NF-kappa B; Skin; Skin Neoplasms; Sodium Compounds; Transplantation, Heterologous; Tumor Suppressor Protein p53

2013
Regulation of cellular Cyclin D1 gene by arsenic is mediated through miR-2909.
    Gene, 2013, Jun-10, Volume: 522, Issue:1

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Arsenic; B-Cell Lymphoma 3 Protein; Cell Line, Tumor; Cell Transformation, Neoplastic; Deubiquitinating Enzyme CYLD; Genes, bcl-1; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Leukocytes, Mononuclear; Lymphoma, B-Cell; MicroRNAs; Protein Biosynthesis; Proto-Oncogene Proteins; Repressor Proteins; Sp1 Transcription Factor; Transcription Factors; Tumor Suppressor Proteins

2013
Chronic exposure to arsenic, estrogen, and their combination causes increased growth and transformation in human prostate epithelial cells potentially by hypermethylation-mediated silencing of MLH1.
    The Prostate, 2013, Volume: 73, Issue:15

    Topics: Adaptor Proteins, Signal Transducing; Arsenic; Cell Cycle; Cell Enlargement; Cell Line; Cell Transformation, Neoplastic; Epithelial Cells; Estrogens; Gene Expression; Gene Silencing; Humans; Male; Methylation; MutL Protein Homolog 1; Nuclear Proteins; Prostate

2013
Arsenic-induced cancer cell phenotype in human breast epithelia is estrogen receptor-independent but involves aromatase activation.
    Archives of toxicology, 2014, Volume: 88, Issue:2

    Topics: Aromatase; Arsenic; Breast Neoplasms; Cell Line; Cell Transformation, Neoplastic; Epithelial Cells; Epithelial-Mesenchymal Transition; Estradiol; Estrogen Receptor alpha; Female; Humans; Mammary Glands, Human; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplastic Stem Cells; Receptors, Estrogen; Toxicity Tests, Chronic

2014
Prediction of the number of activated genes in multiple independent Cd(+2)- and As(+3)-induced malignant transformations of human urothelial cells (UROtsa).
    PloS one, 2014, Volume: 9, Issue:1

    Topics: Algorithms; Arsenic; Cadmium; Cell Line; Cell Transformation, Neoplastic; Cluster Analysis; Computational Biology; Computer Simulation; Epithelial Cells; Humans; Models, Genetic; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Transcriptome; Urothelium

2014
Arsenic-induced sub-lethal stress reprograms human bronchial epithelial cells to CD61¯ cancer stem cells.
    Oncotarget, 2014, Mar-15, Volume: 5, Issue:5

    Topics: Animals; Arsenic; Breast Neoplasms; Bronchi; Cell Line; Cell Transformation, Neoplastic; Cellular Reprogramming; DNA Repair; Epithelium; Female; Gene Expression; Gene Knockdown Techniques; Genes, myc; Humans; Integrin beta3; JNK Mitogen-Activated Protein Kinases; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Neoplasms, Experimental; Neoplastic Stem Cells; Octamer Transcription Factor-3; Ovarian Neoplasms; Phenotype; Phosphorylation; Receptors, Interleukin-2; SOXB1 Transcription Factors; Spheroids, Cellular; Stress, Physiological; Survival Rate

2014
Assessing the impact of As-Cd-Pb metal mixture on cell transformation by two-stage Balb/c 3T3 cell assay.
    Mutagenesis, 2014, Volume: 29, Issue:4

    Topics: 3T3 Cells; Animals; Arsenic; Biological Assay; Cadmium; Cell Cycle; Cell Survival; Cell Transformation, Neoplastic; Cellular Senescence; DNA Damage; Humans; Lead; Metallothionein; Metals, Heavy; Mice; Mice, Inbred BALB C; Mutagenicity Tests; Reactive Oxygen Species

2014
Autophagy inhibition by sustained overproduction of IL6 contributes to arsenic carcinogenesis.
    Cancer research, 2014, Jul-15, Volume: 74, Issue:14

    Topics: Animals; Apoptosis Regulatory Proteins; Arsenic; Autophagy; Beclin-1; Cell Line; Cell Transformation, Neoplastic; Epithelial Cells; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-6; Male; Membrane Proteins; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Protein Binding; RNA, Messenger; STAT3 Transcription Factor; TOR Serine-Threonine Kinases

2014
Arsenite-mediated promotion of anchorage-independent growth of HaCaT cells through placental growth factor.
    The Journal of investigative dermatology, 2015, Volume: 135, Issue:4

    Topics: Animals; Arsenic; Arsenic Poisoning; Arsenites; Bangladesh; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Environmental Pollutants; Humans; Immunohistochemistry; Keratinocytes; MAP Kinase Kinase Kinases; Mice; Placenta Growth Factor; Pregnancy Proteins; Proteasome Endopeptidase Complex; RNA Interference; RNA, Messenger; Signal Transduction; Skin Neoplasms; Urine; Vascular Endothelial Growth Factor Receptor-1; Water Pollutants, Chemical

2015
Role of reactive oxygen species in arsenic-induced transformation of human lung bronchial epithelial (BEAS-2B) cells.
    Biochemical and biophysical research communications, 2015, Jan-09, Volume: 456, Issue:2

    Topics: Apoptosis; Arsenic; Bronchi; Carcinogens, Environmental; Catalase; Cell Line; Cell Transformation, Neoplastic; Humans; Reactive Oxygen Species; Respiratory Mucosa

2015
Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
    Cancer prevention research (Philadelphia, Pa.), 2015, Volume: 8, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Arsenic; Biomarkers, Tumor; Blotting, Western; Case-Control Studies; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cohort Studies; DNA Methylation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; MicroRNAs; Middle Aged; Neoplasm Invasiveness; PTEN Phosphohydrolase; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; TOR Serine-Threonine Kinases; Urinary Bladder; Urinary Bladder Neoplasms; Young Adult

2015
A Potential New Mechanism of Arsenic Carcinogenesis: Depletion of Stem-Loop Binding Protein and Increase in Polyadenylated Canonical Histone H3.1 mRNA.
    Biological trace element research, 2015, Volume: 166, Issue:1

    Topics: Arsenic; Binding Sites; Cell Line; Cell Transformation, Neoplastic; Epigenesis, Genetic; Gene Expression Regulation; Gene Knockdown Techniques; Histones; Humans; Inverted Repeat Sequences; Molecular Sequence Data; mRNA Cleavage and Polyadenylation Factors; Nuclear Proteins; Polyadenylation; RNA, Messenger; S Phase

2015
p38α MAPK is required for arsenic-induced cell transformation.
    Molecular carcinogenesis, 2016, Volume: 55, Issue:5

    Topics: Animals; Arsenic; BALB 3T3 Cells; Cell Transformation, Neoplastic; Cyclic AMP Response Element-Binding Protein; Gene Expression Regulation, Neoplastic; Mice; Mitogen-Activated Protein Kinase 14; Phosphorylation; Signal Transduction; Transcription Factor AP-1

2016
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
    Chemical research in toxicology, 2015, Jun-15, Volume: 28, Issue:6

    Topics: Adult; Aged; Arsenic; Cell Transformation, Neoplastic; DNA Methylation; Female; Humans; Middle Aged; Urinary Bladder Neoplasms; Urothelium; Young Adult

2015
[Dynamic changes of ROS, MDA and SOD during arsenic-induced neoplastic transformation in human keratinocytes].
    Wei sheng yan jiu = Journal of hygiene research, 2015, Volume: 44, Issue:3

    Topics: Arsenic; Arsenites; Cell Line; Cell Transformation, Neoplastic; Humans; Keratinocytes; Oxidation-Reduction; Sodium Compounds

2015
Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced Carcinogenesis.
    The Journal of biological chemistry, 2015, Nov-06, Volume: 290, Issue:45

    Topics: Antioxidants; Apoptosis; Arsenic; Autophagy; bcl-X Protein; Carcinogenesis; Catalase; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Gene Knockdown Techniques; Genes, Tumor Suppressor; Humans; Models, Biological; NF-E2-Related Factor 2; Oncogenes; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; RNA-Binding Proteins; Superoxide Dismutase

2015
Role and mechanism of miR-222 in arsenic-transformed cells for inducing tumor growth.
    Oncotarget, 2016, Apr-05, Volume: 7, Issue:14

    Topics: Animals; Apoptosis; Arsenic; Arsenic Poisoning; Cell Line, Transformed; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; PTEN Phosphohydrolase; Respiratory Mucosa; Up-Regulation

2016
Bhas 42 cell transformation activity of cigarette smoke condensate is modulated by selenium and arsenic.
    Environmental and molecular mutagenesis, 2016, Volume: 57, Issue:3

    Topics: Animals; Arsenic; Carcinogenicity Tests; Cell Line, Transformed; Cell Transformation, Neoplastic; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Mice; Selenium; Smoking; Toxicity Tests

2016
Metal mixture (As-Cd-Pb)-induced cell transformation is modulated by OLA1.
    Mutagenesis, 2016, Volume: 31, Issue:4

    Topics: Adenosine Triphosphatases; Animals; Arsenic; Cadmium; Cell Line; Cell Transformation, Neoplastic; Environmental Pollutants; Gene Knockdown Techniques; Lead; Mice; Oxidative Stress; RNA, Small Interfering

2016
Quantitative Mass Spectrometry Reveals Changes in Histone H2B Variants as Cells Undergo Inorganic Arsenic-Mediated Cellular Transformation.
    Molecular & cellular proteomics : MCP, 2016, Volume: 15, Issue:7

    Topics: Arsenic; Cell Line; Cell Transformation, Neoplastic; Chromatin; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Genetic Variation; HeLa Cells; Histones; Humans; Tandem Mass Spectrometry

2016
Upregulation of glycolysis and oxidative phosphorylation in benzo[α]pyrene and arsenic-induced rat lung epithelial transformed cells.
    Oncotarget, 2016, Jun-28, Volume: 7, Issue:26

    Topics: Adenosine Triphosphate; Animals; Arsenic; Benzo(a)pyrene; Cell Line, Transformed; Cell Transformation, Neoplastic; Epithelial Cells; Female; Glycolysis; Humans; Hypoxia; Lung; Mice; Mice, Nude; Oxidative Phosphorylation; Proteomics; Rats; Up-Regulation

2016
[Biological effects of arsenic and diseases: The mechanisms involved in arsenic-induced carcinogenesis].
    Nihon rinsho. Japanese journal of clinical medicine, 2016, Volume: 74, Issue:7

    Topics: Animals; Arsenic; Carcinogens; Cell Transformation, Neoplastic; Cellular Senescence; DNA Damage; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Mutation

2016
Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism.
    Scientific reports, 2016, 11-23, Volume: 6

    Topics: Apoptosis Regulatory Proteins; Arsenic; Bronchi; Bronchial Neoplasms; Cell Line, Transformed; Cell Transformation, Neoplastic; Epithelial Cells; Humans; MicroRNAs; Neoplasm Proteins; Reactive Oxygen Species; Respiratory Mucosa; RNA-Binding Proteins; RNA, Neoplasm; STAT3 Transcription Factor

2016
Arsenic Induces p62 Expression to Form a Positive Feedback Loop with Nrf2 in Human Epidermal Keratinocytes: Implications for Preventing Arsenic-Induced Skin Cancer.
    Molecules (Basel, Switzerland), 2017, Jan-24, Volume: 22, Issue:2

    Topics: Animals; Arsenic; Autophagy; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Keratinocytes; Male; Mice; NF-E2-Related Factor 2; Protein Binding; RNA, Messenger; Sequestosome-1 Protein; Skin Neoplasms

2017
Genome-wide DNA methylation reprogramming in response to inorganic arsenic links inhibition of CTCF binding, DNMT expression and cellular transformation.
    Scientific reports, 2017, 02-02, Volume: 7

    Topics: Alternative Splicing; Arsenic; CCCTC-Binding Factor; Cell Transformation, Neoplastic; Cellular Reprogramming; Chromosomes, Human; CpG Islands; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epithelial-Mesenchymal Transition; Gene Ontology; Genome, Human; Humans; Promoter Regions, Genetic; Protein Binding; Reproducibility of Results; Transcription, Genetic

2017
Induction of cytoplasmic accumulation of p53: a mechanism for low levels of arsenic exposure to predispose cells for malignant transformation.
    Cancer research, 2008, Nov-15, Volume: 68, Issue:22

    Topics: Animals; Arsenic; Cell Line, Tumor; Cell Transformation, Neoplastic; Cytoplasm; DNA Damage; Extracellular Signal-Regulated MAP Kinases; Fluorouracil; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Promoter Regions, Genetic; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53

2008
Comparison of gene expression profiles in HepG2 cells exposed to arsenic, cadmium, nickel, and three model carcinogens for investigating the mechanisms of metal carcinogenesis.
    Environmental and molecular mutagenesis, 2009, Volume: 50, Issue:1

    Topics: Arsenic; Base Sequence; Cadmium; Carcinogens; Cell Line; Cell Transformation, Neoplastic; DNA Primers; Gene Expression Profiling; Humans; Nickel; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction

2009
Acute promyelocytic leukemia--weapons of mass differentiation.
    The New England journal of medicine, 2009, Feb-26, Volume: 360, Issue:9

    Topics: Animals; Antineoplastic Agents; Arsenic; Cell Differentiation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Mice; Oncogene Proteins, Fusion; Tretinoin

2009
Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
    Carcinogenesis, 2009, Volume: 30, Issue:6

    Topics: Aged; Apoptosis; Arsenic; Bowen's Disease; CD4-Positive T-Lymphocytes; Cell Transformation, Neoplastic; Cells, Cultured; Fas Ligand Protein; Female; Humans; Immunity, Active; Keratinocytes; Male; Middle Aged; Skin Neoplasms

2009
Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells.
    Carcinogenesis, 2009, Volume: 30, Issue:10

    Topics: 20-Hydroxysteroid Dehydrogenases; Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Animals; Arsenic; Base Sequence; Cell Transformation, Neoplastic; DNA Primers; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Keratinocytes; Mice; NIH 3T3 Cells; Transfection

2009
Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells.
    Toxicology and applied pharmacology, 2009, Dec-01, Volume: 241, Issue:2

    Topics: Animals; Arsenic; Cell Line; Cell Transformation, Neoplastic; CpG Islands; DNA Methylation; Mice; Mice, SCID; Oligonucleotide Array Sequence Analysis; Organometallic Compounds; Promoter Regions, Genetic; Urothelium

2009
Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype.
    Environmental health perspectives, 2010, Volume: 118, Issue:1

    Topics: Adult Stem Cells; Animals; Arsenic; Arsenites; Carcinogens, Environmental; Cell Line; Cell Transformation, Neoplastic; Gene Expression; Humans; Male; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Nude; Neoplasms, Experimental; Neoplastic Stem Cells; Phenotype; Prostate; PTEN Phosphohydrolase; Spheroids, Cellular; Transplantation, Heterologous

2010
Reduced reactive oxygen species-generating capacity contributes to the enhanced cell growth of arsenic-transformed epithelial cells.
    Cancer research, 2010, Jun-15, Volume: 70, Issue:12

    Topics: Arsenic; Blotting, Western; Bronchi; Catalase; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Colony-Forming Units Assay; Electrophoretic Mobility Shift Assay; Epithelial Cells; Fluorescent Antibody Technique; Humans; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Superoxide Dismutase

2010
Immunological profile of arsenic toxicity: a hint towards arsenic-induced carcinogenesis.
    Asian Pacific journal of cancer prevention : APJCP, 2010, Volume: 11, Issue:2

    Topics: Alkylating Agents; Animals; Apoptosis; Arsenic; Caspases; Cell Transformation, Neoplastic; Cytokines; Ethylnitrosourea; Female; Humans; Male; Mice; Neoplasms, Experimental; Tissue Distribution

2010
Activation and up-regulation of translation initiation factor 4B contribute to arsenic-induced transformation.
    Molecular carcinogenesis, 2011, Volume: 50, Issue:7

    Topics: Animals; Arsenic; Cell Line; Cell Transformation, Neoplastic; Eukaryotic Initiation Factors; Gene Knockdown Techniques; Genes, myc; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases; Up-Regulation

2011
Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b.
    Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 121, Issue:1

    Topics: Animals; Arsenic; Base Sequence; Bronchi; Cell Transformation, Neoplastic; DNA Methylation; DNA Primers; Epithelial Cells; Humans; Mice; Mice, Nude; MicroRNAs; Reverse Transcriptase Polymerase Chain Reaction

2011
Mitochondrial biogenesis drives tumor cell proliferation.
    The American journal of pathology, 2011, Volume: 178, Issue:5

    Topics: Animals; Arsenic; Bowen's Disease; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Mitochondria; Skin Neoplasms

2011
Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers.
    The American journal of pathology, 2011, Volume: 178, Issue:5

    Topics: Aged; Arsenic; Arsenic Poisoning; Blotting, Western; Bowen's Disease; Cell Proliferation; Cell Respiration; Cell Transformation, Neoplastic; DNA-Binding Proteins; Humans; Immunohistochemistry; Keratinocytes; Mitochondria; Mitochondrial Proteins; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Transcription Factors

2011
Reply to "Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b".
    Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 122, Issue:2

    Topics: Animals; Arsenic; Bronchi; Cell Transformation, Neoplastic; Humans; MicroRNAs

2011
Devastating environmental threads: arsenic exposure and carcinogenesis.
    The Kaohsiung journal of medical sciences, 2011, Volume: 27, Issue:9

    Topics: Arsenic; Carcinogens, Environmental; Cell Transformation, Neoplastic; Humans

2011
Akt activation is responsible for enhanced migratory and invasive behavior of arsenic-transformed human bronchial epithelial cells.
    Environmental health perspectives, 2012, Volume: 120, Issue:1

    Topics: Arsenic; Bronchi; Cell Line; Cell Movement; Cell Transformation, Neoplastic; Epithelial Cells; Homeodomain Proteins; Humans; Neoplasm Invasiveness; Proto-Oncogene Proteins c-akt; Repressor Proteins; Respiratory Mucosa; Transcription Factors; Transcriptional Activation; Zinc Finger E-box Binding Homeobox 2; Zinc Finger E-box-Binding Homeobox 1

2012
Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic.
    Toxicological sciences : an official journal of the Society of Toxicology, 2012, Volume: 125, Issue:1

    Topics: Antigens, CD34; Arsenic; Biomarkers; Cell Line; Cell Transformation, Neoplastic; Fluorescent Antibody Technique; Humans; Keratinocytes; Matrix Metalloproteinase 9; Microscopy, Fluorescence; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Skin Neoplasms

2012
Barium promotes anchorage-independent growth and invasion of human HaCaT keratinocytes via activation of c-SRC kinase.
    PloS one, 2011, Volume: 6, Issue:10

    Topics: Animals; Arsenic; Bangladesh; Barium; Cell Adhesion; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; CSK Tyrosine-Protein Kinase; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Focal Adhesion Protein-Tyrosine Kinases; Humans; Keratinocytes; Matrix Metalloproteinase 14; Melanocytes; Mice; NIH 3T3 Cells; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; src-Family Kinases; Vietnam; Water Pollution; Water Wells

2011
Role of oxidative stress in transformation induced by metal mixture.
    Oxidative medicine and cellular longevity, 2011, Volume: 2011

    Topics: Acetylcysteine; Air Pollutants; Animals; Arsenic; BALB 3T3 Cells; Cadmium; Carcinogens, Environmental; Cell Survival; Cell Transformation, Neoplastic; Free Radical Scavengers; Humans; Lead; Mice; Oxidative Stress; Reactive Oxygen Species

2011
Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype.
    Environmental health perspectives, 2012, Volume: 120, Issue:6

    Topics: Arsenic; Blotting, Western; Cell Line, Tumor; Cell Transformation, Neoplastic; Epithelial Cells; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Male; Matrix Metalloproteinases; Neoplastic Stem Cells; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction

2012
Bad neighbors: arsenic-induced tumor cells convert normal stem cells into a cancerous phenotype.
    Environmental health perspectives, 2012, Volume: 120, Issue:6

    Topics: Arsenic; Cell Transformation, Neoplastic; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplastic Stem Cells; Prostatic Neoplasms

2012
Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer.
    Metallomics : integrated biometal science, 2012, Volume: 4, Issue:8

    Topics: Arsenic; Bronchi; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Chromium; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Nickel; Vanadium

2012
Therapeutic profile of T11TS vs. T11TS+MiADMSA: a hunt for a more effective therapeutic regimen for arsenic exposure.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:6

    Topics: Animals; Apoptosis; Arsenic; Arsenic Poisoning; CD2 Antigens; Cell Transformation, Neoplastic; Chelating Agents; Chelation Therapy; Cytokines; Drug Therapy, Combination; Environmental Exposure; Lymphocytes; Mice; Oxidative Stress; Succimer

2012
Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation.
    Epigenetics, 2012, Volume: 7, Issue:11

    Topics: Animals; Arsenic; Cadherins; Carcinoma; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Female; Genes, Homeobox; Histones; Humans; Lysine; Male; Mice; Mice, Nude; Multigene Family; Neoplasm Transplantation; Prostatic Neoplasms; Protein Processing, Post-Translational

2012
Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype.
    Chemical research in toxicology, 2013, Jan-18, Volume: 26, Issue:1

    Topics: AC133 Antigen; Animals; Antigens, CD; Arsenic; CD24 Antigen; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Cyclooxygenase 2; Glycoproteins; Humans; Kidney; Kidney Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metallothionein; Mice; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplastic Stem Cells; Peptides; Rats; Stem Cells; Superoxide Dismutase; Superoxide Dismutase-1

2013
Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies.
    Environmental health perspectives, 2002, Volume: 110 Suppl 5

    Topics: Animals; Arsenic; Arsenites; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Disease Models, Animal; DNA Damage; DNA Repair; Risk Assessment; Skin Neoplasms; Teratogens; Ultraviolet Rays; Water Supply

2002
The molecular mechanisms of arsenic-induced cell transformation and apoptosis.
    Environmental health perspectives, 2002, Volume: 110 Suppl 5

    Topics: Animals; Apoptosis; Arsenic; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, p53; Humans; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinases; Phosphorylation; Signal Transduction; Skin

2002
Proteomic analyses of arsenic-induced cell transformation with SELDI-TOF ProteinChip technology.
    Journal of cellular biochemistry, 2003, Jan-01, Volume: 88, Issue:1

    Topics: Animals; Arsenic; Arsenites; Benzo(a)pyrene; Carcinogens; Cell Line, Transformed; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Protein Array Analysis; Proteome; Rats; Rats, Inbred F344; Time Factors; Tumor Cells, Cultured

2003
Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: application of cDNA microarray technology.
    Environmental health perspectives, 2002, Volume: 110 Suppl 6

    Topics: Arsenic; Cell Culture Techniques; Cell Transformation, Neoplastic; DNA Repair; Gene Expression Profiling; Gene Expression Regulation; Genetic Markers; Humans; Keratinocytes; Methylnitronitrosoguanidine; Oligonucleotide Array Sequence Analysis; Protein Kinases; Risk Assessment; Xenobiotics

2002
UV filters with antagonistic action at androgen receptors in the MDA-kb2 cell transcriptional-activation assay.
    Toxicological sciences : an official journal of the Society of Toxicology, 2003, Volume: 74, Issue:1

    Topics: Arsenic; Biomarkers; Carcinogens; Cell Line; Cell Transformation, Neoplastic; DNA Primers; Gene Expression Regulation, Neoplastic; Humans; Keratinocytes; Metals; Methylnitronitrosoguanidine; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction

2003
Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.
    Environmental health perspectives, 2005, Volume: 113, Issue:9

    Topics: Androgen Antagonists; Androgens; Animals; Arsenic; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Dihydrotestosterone; Epidermal Growth Factor; Epithelial Cells; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Flutamide; Gene Expression Regulation; Humans; Male; Mice; Pituitary Gland; Prostate; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger

2005
Aurora-A overexpression associates with Ha-ras codon-12 mutation and blackfoot disease endemic area in bladder cancer.
    Cancer letters, 2006, Sep-08, Volume: 241, Issue:1

    Topics: Arsenic; Aurora Kinases; Cell Line, Tumor; Cell Transformation, Neoplastic; Codon; Endemic Diseases; Genes, ras; Humans; Mutation; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Protein Serine-Threonine Kinases; RNA, Messenger

2006
Proteomic and biochemical analyses of in vitro carcinogen-induced lung cell transformation: synergism between arsenic and benzo[a]pyrene.
    Proteomics, 2006, Volume: 6, Issue:5

    Topics: Actinin; Actins; Animals; Arsenic; Benzo(a)pyrene; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Electrophoresis, Gel, Two-Dimensional; Extracellular Signal-Regulated MAP Kinases; Intermediate Filament Proteins; Lung; MAP Kinase Signaling System; Membrane Glycoproteins; Nerve Tissue Proteins; Peptides; Peripherins; Proteome; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2006
Enhanced expression of metallothionein isoform 3 protein in tumor heterotransplants derived from As+3- and Cd+2-transformed human urothelial cells.
    Toxicological sciences : an official journal of the Society of Toxicology, 2006, Volume: 93, Issue:2

    Topics: Animals; Arsenic; Biomarkers, Tumor; Breast Neoplasms; Cadmium; Cell Transformation, Neoplastic; Cells, Cultured; Female; Humans; Immunohistochemistry; Male; Metallothionein; Metallothionein 3; Mice; Neoplasm Transplantation; Prostatic Neoplasms; Protein Isoforms; RNA, Messenger; Transplantation, Heterologous; Urinary Bladder Neoplasms

2006
Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells.
    Toxicology and applied pharmacology, 2006, Nov-01, Volume: 216, Issue:3

    Topics: Animals; Arsenic; Arsenites; Azacitidine; Blotting, Western; Carcinogens; Cell Cycle; Cell Line; Cell Transformation, Neoplastic; Dealkylation; Decitabine; DNA, Neoplasm; Gene Expression; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Growth; Intercellular Signaling Peptides and Proteins; Liver Neoplasms; Rats; Reverse Transcriptase Polymerase Chain Reaction; Stress, Physiological

2006
Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.
    Environmental health perspectives, 2007, Volume: 115, Issue:2

    Topics: Androgens; Arsenic; Blotting, Western; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Environmental Pollutants; Epithelial Cells; Humans; Male; MAP Kinase Signaling System; Models, Biological; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins p21(ras); raf Kinases; Receptor, ErbB-2; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction

2007
GATA-1 and Gfi-1B interplay to regulate Bcl-xL transcription.
    Molecular and cellular biology, 2007, Volume: 27, Issue:12

    Topics: Apoptosis; Arsenic; bcl-X Protein; Benzamides; Binding Sites; Cell Line; Cell Line, Transformed; Cell Transformation, Neoplastic; Chromatin Immunoprecipitation; Fusion Proteins, bcr-abl; GATA1 Transcription Factor; Gene Expression Regulation; Genes, Reporter; Humans; Imatinib Mesylate; K562 Cells; Luciferases; Piperazines; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins; Pyrimidines; Repressor Proteins; Retroviridae; Transcription, Genetic; Transcriptional Activation

2007
Arsenic-induced changes in the gene expression of lung epithelial L2 cells: implications in carcinogenesis.
    BMC genomics, 2008, Mar-03, Volume: 9

    Topics: Animals; Arsenic; Carcinogens; Cell Differentiation; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; Cluster Analysis; Dose-Response Relationship, Drug; Epithelial Cells; Gene Expression; Lung; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Rats

2008
Molecular basis for effects of carcinogenic heavy metals on inducible gene expression.
    Environmental health perspectives, 1998, Volume: 106 Suppl 4

    Topics: Animals; Arsenic; Cell Transformation, Neoplastic; Chick Embryo; Chromium; Environmental Exposure; Gene Expression; Genetic Markers; Humans; Neoplasms; Promoter Regions, Genetic; Rats; Toxicity Tests; Transcription Factors

1998
Arsenic, dioxin, and the promotional step in cancer creation.
    Ecotoxicology and environmental safety, 2000, Volume: 45, Issue:3

    Topics: Arsenic; Carcinogens; Cell Transformation, Neoplastic; Environmental Exposure; Female; Humans; Incidence; Male; Neoplasms; Occupational Exposure; Polychlorinated Dibenzodioxins; Sex Distribution; Survival Rate

2000
Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis.
    Biochemical and biophysical research communications, 2001, Sep-14, Volume: 287, Issue:1

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Arsenic; Cacodylic Acid; Carcinogenicity Tests; Cell Transformation, Neoplastic; Chromatography, High Pressure Liquid; Deoxyguanosine; Enzyme-Linked Immunosorbent Assay; Female; Male; Mice; Mice, Hairless; Tissue Distribution

2001
Acquisition of apoptotic resistance in arsenic-induced malignant transformation: role of the JNK signal transduction pathway.
    Carcinogenesis, 2002, Volume: 23, Issue:1

    Topics: Animals; Apoptosis; Arsenic; bcl-2-Associated X Protein; Blotting, Western; Cell Line, Transformed; Cell Transformation, Neoplastic; Drug Resistance; Enzyme Activation; Flow Cytometry; Hepatocytes; In Situ Nick-End Labeling; Indoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred F344; Signal Transduction

2002
Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts.
    Cancer research, 1979, Volume: 39, Issue:3

    Topics: Animals; Arsenic; Beryllium; Cadmium; Cell Transformation, Neoplastic; Cells, Cultured; Chromium; Cricetinae; Dose-Response Relationship, Drug; Embryo, Mammalian; Female; Maternal-Fetal Exchange; Mesocricetus; Metals; Nickel; Pregnancy

1979
Novel ATP-binding heat-inducible protein of Mr = 37,000 that is sensitive to transformation in BALB/3T3 cells.
    Journal of cellular physiology, 1990, Volume: 143, Issue:3

    Topics: 2,2'-Dipyridyl; Adenosine Triphosphate; Animals; Arsenic; Arsenites; Calcimycin; Carrier Proteins; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Chick Embryo; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum Chaperone BiP; Fibroblasts; Heat-Shock Proteins; Methionine; Mice; Mice, Inbred BALB C; Precipitin Tests; Sepharose; Sulfur Radioisotopes; Tetradecanoylphorbol Acetate; Tunicamycin

1990
Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation.
    Carcinogenesis, 1987, Volume: 8, Issue:6

    Topics: Animals; Arsenates; Arsenic; Arsenites; Biological Transport; Biotransformation; Cell Transformation, Neoplastic; Cells, Cultured; Kinetics; Mice; Mice, Inbred BALB C; Sodium Compounds

1987
Different modes of action of sodium arsenite, 3-aminobenzamide, and caffeine on the enhancement of ethyl methanesulfonate clastogenicity.
    Cytogenetics and cell genetics, 1986, Volume: 41, Issue:4

    Topics: Animals; Arsenic; Arsenites; Benzamides; Caffeine; Cell Cycle; Cell Line; Cell Transformation, Neoplastic; Chromatids; Chromosome Aberrations; Cricetinae; Cricetulus; Female; Methyl Methanesulfonate; Ovary; Sodium Compounds; Sulfhydryl Reagents

1986
Carcinogenicity and mutagenicity of some metals and their compounds.
    IARC scientific publications, 1986, Issue:71

    Topics: Animals; Arsenic; Cadmium; Carcinogens; Cell Transformation, Neoplastic; Chromium; Chromosome Aberrations; DNA; DNA Damage; DNA-Directed DNA Polymerase; Humans; Metals; Microsomes, Liver; Mutagens; Nickel; Nucleoproteins; Platinum; Tin; Transcription, Genetic

1986
Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effects in Syrian hamster embryo cells in culture.
    Carcinogenesis, 1985, Volume: 6, Issue:10

    Topics: Animals; Arsenates; Arsenic; Arsenites; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; Chromosome Aberrations; Cricetinae; Drug Resistance; Mutation; Ouabain; Sister Chromatid Exchange; Sodium Compounds; Thioguanine

1985
Arsenic as an inhibitor of the enzymes concerned in cellular recovery (dark repair).
    German medical monthly, 1969, Volume: 14, Issue:12

    Topics: Adult; Animals; Arsenic; Autoradiography; Cell Transformation, Neoplastic; Enzyme Repression; Humans; In Vitro Techniques; Male; Radiation Injuries, Experimental; Skin; Skin Neoplasms; Skin Transplantation; Transplantation, Homologous; Tritium

1969